The Medicines Company to Participate in 33rd Annual J.P. Morgan Healthcare Conference

05 Jan 2015

The Medicines Company (NASDAQ:MDCO) is scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 12th at 7:30 AM PST / 10:30 AM EST.

The session will be webcast with a link available at The Medicines Company’s website

About The Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.


Investor Relations:
The Medicines Company
Neera Dahiya Ravindran, MD, +1 (973) 290-6044
Vice President, Investor Relations & Strategic Planning
Bob Laverty, +1-973-290-6162
Vice President, Communications
Office of D.E.S.I.GN

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information